Seres Therapeutics logo
Seres Therapeutics MCRB
$ 0.77 5.49%

Quarterly report 2024-Q3
added 11-13-2024

report update icon

Seres Therapeutics EV/EBITDA Ratio 2011-2024 | MCRB

Annual EV/EBITDA Ratio Seres Therapeutics

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
-13.3 -23.2 -2.37 -1.77 -4.58 -3.62 -10.3 - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
-1.77 -23.2 -8.45